Article #31864

Scientists developing vaccines and anti-tick treatments amid growing concern over spread of disease

Cases of Lyme disease have risen more than 20% in England in the past year, public health experts have revealed, as pharmaceutical companies work to create new vaccines and drugs to tackle the tick-borne illness.

According to data from the UK Health Security Agency (UKHSA), published as part of its One Health vector-borne disease surveillance report, there were 1,168 laboratory-confirmed cases of Lyme disease in 2025, up from 959 in 2024 – an increase of 22%. However, the figure is similar to that recorded in 2023, when there were 1,151 confirmed cases.